A retrospective, multicenter, observational study to evaluate clinical outcomes of lorlatinib after alectinib in patients with ALK-positive non-small cell lung cancer in Japan

JTO Clinical and Research Reports(2023)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要